Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-catechin | multiple interactions | ISO | ZMIZ2 (Homo sapiens) | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of ZMIZ2 mRNA | CTD | PMID:24763279 | 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of ZMIZ2 mRNA | CTD | PMID:30723492 | 17beta-estradiol | multiple interactions | ISO | ZMIZ2 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of ZMIZ2 mRNA | CTD | PMID:20660070 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Zmiz2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of ZMIZ2 mRNA and [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ZMIZ2 mRNA | CTD | PMID:16214954 and PMID:25975270 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Zmiz2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZMIZ2 mRNA | CTD | PMID:26377647 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ZMIZ2 mRNA | CTD | PMID:21215274 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of ZMIZ2 mRNA] | CTD | PMID:21215274 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Zmiz2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ZMIZ2 mRNA | CTD | PMID:18796159 | 2-palmitoylglycerol | increases expression | ISO | ZMIZ2 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of ZMIZ2 mRNA | CTD | PMID:37199045 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of ZMIZ2 mRNA | CTD | PMID:30047161 | acrolein | multiple interactions | ISO | ZMIZ2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ZMIZ2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ZMIZ2 mRNA | CTD | PMID:32699268 | all-trans-retinoic acid | increases expression | ISO | ZMIZ2 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of ZMIZ2 mRNA | CTD | PMID:33167477 | alpha-pinene | multiple interactions | ISO | ZMIZ2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ZMIZ2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ZMIZ2 mRNA | CTD | PMID:32699268 | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of ZMIZ2 mRNA | CTD | PMID:30047161 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of ZMIZ2 mRNA | CTD | PMID:30779732 | antirheumatic drug | decreases expression | ISO | ZMIZ2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of ZMIZ2 mRNA | CTD | PMID:24449571 | arsane | multiple interactions | ISO | ZMIZ2 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ZMIZ2 mRNA | CTD | PMID:32525701 | arsenic atom | multiple interactions | ISO | ZMIZ2 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ZMIZ2 mRNA | CTD | PMID:32525701 | benzo[a]pyrene | increases methylation | ISO | ZMIZ2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of ZMIZ2 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | ISO | ZMIZ2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of ZMIZ2 promoter | CTD | PMID:27901495 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of ZMIZ2 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ZMIZ2 mRNA | CTD | PMID:30816183 and PMID:34947998 | buta-1,3-diene | decreases expression | ISO | Zmiz2 (Mus musculus) | 6480464 | 1 and 3-butadiene results in decreased expression of ZMIZ2 mRNA | CTD | PMID:29038090 | butanal | increases expression | ISO | ZMIZ2 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of ZMIZ2 mRNA | CTD | PMID:26079696 | C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of ZMIZ2 mRNA | CTD | PMID:19167457 | cadmium atom | multiple interactions | ISO | ZMIZ2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZMIZ2 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | ZMIZ2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZMIZ2 mRNA | CTD | PMID:35301059 | chlorpyrifos | decreases expression | ISO | Zmiz2 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of ZMIZ2 mRNA | CTD | PMID:32715474 | chlorpyrifos | increases expression | ISO | Zmiz2 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of ZMIZ2 mRNA | CTD | PMID:37019170 | clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of ZMIZ2 mRNA | CTD | PMID:17602206 | dicrotophos | increases expression | ISO | ZMIZ2 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of ZMIZ2 mRNA | CTD | PMID:28302478 | ethanol | increases expression | ISO | Zmiz2 (Mus musculus) | 6480464 | Ethanol results in increased expression of ZMIZ2 mRNA | CTD | PMID:30319688 | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of ZMIZ2 mRNA | CTD | PMID:24136188 | formaldehyde | increases expression | ISO | ZMIZ2 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of ZMIZ2 mRNA | CTD | PMID:23649840 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of ZMIZ2 mRNA | CTD | PMID:33387578 | methamphetamine | increases expression | ISO | Zmiz2 (Mus musculus) | 6480464 | Methamphetamine results in increased expression of ZMIZ2 mRNA | CTD | PMID:26307267 | methidathion | increases expression | ISO | Zmiz2 (Mus musculus) | 6480464 | methidathion results in increased expression of ZMIZ2 mRNA | CTD | PMID:34813904 | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of ZMIZ2 mRNA | CTD | PMID:30047161 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ZMIZ2 mRNA and [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of ZMIZ2 promoter | CTD | PMID:25374375 | nefazodone | decreases expression | EXP | | 6480464 | nefazodone results in decreased expression of ZMIZ2 mRNA | CTD | PMID:24136188 | nitrofen | decreases expression | EXP | | 6480464 | nitrofen results in decreased expression of ZMIZ2 mRNA | CTD | PMID:26720608 | ozone | multiple interactions | ISO | ZMIZ2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ZMIZ2 mRNA more ... | CTD | PMID:32699268 | paraquat | decreases expression | ISO | Zmiz2 (Mus musculus) | 6480464 | Paraquat results in decreased expression of ZMIZ2 mRNA | CTD | PMID:21371552 | paraquat | increases expression | ISO | Zmiz2 (Mus musculus) | 6480464 | Paraquat results in increased expression of ZMIZ2 mRNA | CTD | PMID:21371552 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Zmiz2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ZMIZ2 mRNA | CTD | PMID:36331819 | phenobarbital | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ZMIZ2 mRNA and [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of ZMIZ2 promoter | CTD | PMID:25374375 | progesterone | multiple interactions | ISO | ZMIZ2 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of ZMIZ2 mRNA | CTD | PMID:20660070 | propanal | increases expression | ISO | ZMIZ2 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of ZMIZ2 mRNA | CTD | PMID:26079696 | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of ZMIZ2 mRNA | CTD | PMID:28374803 | sodium arsenate | multiple interactions | ISO | ZMIZ2 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ZMIZ2 mRNA | CTD | PMID:32525701 | sodium dodecyl sulfate | increases expression | ISO | ZMIZ2 (Homo sapiens) | 6480464 | Sodium Dodecyl Sulfate results in increased expression of ZMIZ2 mRNA | CTD | PMID:31734321 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of ZMIZ2 mRNA | CTD | PMID:31150632 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of ZMIZ2 mRNA | CTD | PMID:30723492 | triphenyl phosphate | decreases expression | EXP | | 6480464 | triphenyl phosphate results in decreased expression of ZMIZ2 mRNA | CTD | PMID:30589522 | triptonide | affects expression | ISO | Zmiz2 (Mus musculus) | 6480464 | triptonide affects the expression of ZMIZ2 mRNA | CTD | PMID:33045310 | tungsten | decreases expression | ISO | Zmiz2 (Mus musculus) | 6480464 | Tungsten results in decreased expression of ZMIZ2 mRNA | CTD | PMID:30912803 | tunicamycin | decreases expression | ISO | ZMIZ2 (Homo sapiens) | 6480464 | Tunicamycin results in decreased expression of ZMIZ2 mRNA | CTD | PMID:22378314 | valproic acid | increases methylation | ISO | ZMIZ2 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of ZMIZ2 gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | ZMIZ2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ZMIZ2 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | ZMIZ2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ZMIZ2 mRNA | CTD | PMID:23179753 and PMID:28001369 | vincristine | increases expression | ISO | ZMIZ2 (Homo sapiens) | 6480464 | Vincristine results in increased expression of ZMIZ2 mRNA | CTD | PMID:23649840 | zinc atom | decreases expression | ISO | ZMIZ2 (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of ZMIZ2 mRNA | CTD | PMID:18356318 | zinc(0) | decreases expression | ISO | ZMIZ2 (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of ZMIZ2 mRNA | CTD | PMID:18356318 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
